Cyclosporine-induced changes in drug metabolizing enzymes in hyperlipemic rabbit kidneys could explain its toxicity

References

• Aebi HE. (1963). Detection and fixation of radiation-produced peroxide by enzymes. Radiat Res (Suppl 3):130–152.
   PubMedGoogle Scholar
• Ahmed SS, Napoli KL, Strobel HW. (1995). Oxygen radical formation during cytochrome P450-catalyzed cyclosporine metabolism in rat and human liver microsomes at varying hydrogen ion concentrations. Mol Cell Biochem 151:131–140.
   PubMed Web of Science ®Google Scholar
• Bai S, Brunner LJ, Stepkowski SM, Napoli KL, Kahan BD. (2001). Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1. Transplantation 71:1585–1592.
   PubMedGoogle Scholar
• Borel JF, Baumann G, Chapman I, Donatsch P, Fahr A, Mueller EA, Vigouret JM. (1996). In vivo pharmacological effects of ciclosporin and some analogues. Adv Pharmacol 35:115–246.
   PubMedGoogle Scholar
• Campbell WB, Falck JR. (2007). Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. Hypertension 49:590–596.
   PubMed Web of Science ®Google Scholar
• Caro AA, Cederbaum AI. (2004). Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27–42.
   PubMed Web of Science ®Google Scholar
• Constan AA, Sprankle CS, Peters JM, Kedderis GL, Everitt JI, Wong BA, Gonzalez FL, Butterworth BE. (1999). Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicol Appl Pharmacol 160:120–126.
   PubMed Web of Science ®Google Scholar
• Durak I, Cetin R, Candir O, Devrim E, Kilicoglu B, Avci A. (2007). Black grape and garlic extracts protect against cyclosporine a nephrotoxicity. Immunol Invest 36:105–114.
   PubMed Web of Science ®Google Scholar
• Durak I, Kaçmaz M, Cimen MY, Büyükkoçak S, Elgün S, Oztürk HS. (2002). The effects of cyclosporine on antioxidant enzyme activities and malondialdehyde levels in rabbit hepatic tissues. Transpl Immunol 10:255–258.
   PubMed Web of Science ®Google Scholar
• Durak I, Karabacak HI, Büyükkoçak S, Cimen MY, Kaçmaz M, Omeroglu E, Oztürk HS. (1998). Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 78:207–211.
   PubMed Web of Science ®Google Scholar
• Elbarbry F, Wilby K, Alcorn J. (2006). Validation of a HPLC method for the determination of p-nitrophenol hydroxylase activity in rat hepatic microsomes. J Chromatogr B Analyt Technol Biomed Life Sci 834:199–203.
   PubMedGoogle Scholar
• Elbarbry FA, McNamara PJ, Alcorn J. (2007). Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat. J Biochem Mol Toxicol 21:41–50.
   PubMed Web of Science ®Google Scholar
• Ergüder IB, Cetin R, Devrim E, Kiliçoglu B, Avci A, Durak I. (2005). Effects of cyclosporine on oxidant/antioxidant status in rat ovary tissues: protective role of black grape extract. Int Immunopharmacol 5:1311–1315.
   PubMed Web of Science ®Google Scholar
• Griffith OW. (1980). Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106:207–212.
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jakoby WB. (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88.
   PubMed Web of Science ®Google Scholar
• Hoagland KM, Maier KG, Moreno C, Yu M, Roman RJ. (2001). Cytochrome P450 metabolites of arachidonic acid: novel regulators of renal function. Nephrol Dial Transplant 16:2283–2285.
   PubMedGoogle Scholar
• Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, Floege J. (2000). Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11:669–683.
   PubMed Web of Science ®Google Scholar
• Jung CH, Thomas JA. (1996). S-glutathiolated hepatocyte proteins and insulin disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein disulfide isomerase, and glutathione. Arch Biochem Biophys 335:61–72.
   PubMedGoogle Scholar
• Kahan BD. (1989). Cyclosporine. N Engl J Med 321:1725–1738.
   PubMed Web of Science ®Google Scholar
• Kang JS, Wanibuchi H, Morimura K, Puatanachokchai R, Salim EI, Hagihara A, Seki S, Fukushima S. (2005). Enhancement by estradiol 3-benzoate in thioacetamide-induced liver cirrhosis of rats. Toxicol Sci 85:720–726.
   PubMedGoogle Scholar
• Kang JS, Wanibuchi H, Morimura K, Wongpoomchai R, Chusiri Y, Gonzalez FJ, Fukushima S. (2008). Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. Toxicol Appl Pharmacol 228:295–300.
   PubMed Web of Science ®Google Scholar
• Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O’Donnell MP. (1991). Hyperlipidemia and progressive renal disease. Kidney Int Suppl 31:S41–S48.
   Google Scholar
• Krauskopf A, Buetler TM, Nguyen NS, Macé K, Ruegg UT. (2002). Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450. Br J Pharmacol 135:977–986.
   PubMedGoogle Scholar
• L’Azou B, Medina J, Frieauff W, Cordier A, Cambar J, Wolf A. (1999). In vitro models to study mechanisms involved in cyclosporine A-mediated glomerular contraction. Arch Toxicol 73:337–345.
   PubMedGoogle Scholar
• Lavezzi AM, Ottaviani G, Matturri L. (2005). Biology of the smooth muscle cells in human atherosclerosis. APMIS 113:112–121.
   PubMedGoogle Scholar
• Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. (2000). CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis. J Clin Invest 105:1067–1075.
   PubMed Web of Science ®Google Scholar
• Lin H, Hollenberg PF. (2001). N-nitrosodimethylamine-mediated formation of oxidized and methylated dna bases in a cytochrome P450 2E1 expressing cell line. Chem Res Toxicol 14:562–566.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Lutz M, Bonilla S, Concha J, Alvarado J, Barraza P. (1998). Effect of dietary oils, cholesterol and antioxidant vitamin supplementation on liver microsomal fluidity and xenobiotic-metabolizing enzymes in rats. Ann Nutr Metab 42:350–359.
   PubMed Web of Science ®Google Scholar
• Mathers J, Fraser JA, McMahon M, Saunders RD, Hayes JD, McLellan LI. (2004). Antioxidant and cytoprotective responses to redox stress. Biochem Soc Symp 71:157–176.
   PubMedGoogle Scholar
• Mihatsch MJ, Ryffel B, Gudat F. (1995). The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int Suppl 52:S63–S69.
   PubMedGoogle Scholar
• Misra HP, Fridovich I. (1972). The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem 247:6960–6962.
   PubMed Web of Science ®Google Scholar
• Mitsuguchi Y, Ito T, Ohwada K. (2008). Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia. Comp Med 58:465–480.
   PubMedGoogle Scholar
• Morimoto M, Hagbjörk AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, Albano E, French SW. (1993). Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 10:459–464.
   PubMed Web of Science ®Google Scholar
• Mühlfeld AS, Spencer MW, Hudkins KL, Kirk E, LeBoeuf RC, Alpers CE. (2004). Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice. Kidney Int 66:1393–1402.
   PubMed Web of Science ®Google Scholar
• Niwa T, Yamamoto S, Saito M, Shiraga T, Takagi A. (2007). Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. Yakugaku Zasshi 127:209–216.
   PubMed Web of Science ®Google Scholar
• Novak RF, Woodcroft KJ. (2000). The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch Pharm Res 23:267–282.
   PubMed Web of Science ®Google Scholar
• Palomero J, Galán AI, Muñoz ME, Tuñón MJ, González-Gallego J, Jiménez R. (2001). Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes. Free Radic Biol Med 30:836–845.
   PubMed Web of Science ®Google Scholar
• Pérez de Lema G, Arribas I, Prieto A, Parra T, de Arriba G, Rodríguez-Puyol D, Rodríguez-Puyol M. (1998). Cyclosporin A-induced hydrogen peroxide synthesis by cultured human mesangial cells is blocked by exogenous antioxidants. Life Sci 62:1745–1753.
   PubMed Web of Science ®Google Scholar
• Person RE, Chen H, Fantel AG, Juchau MR. (2000). Enzymic catalysis of the accumulation of acetaldehyde from ethanol in human prenatal cephalic tissues: evaluation of the relative contributions of CYP2E1, alcohol dehydrogenase, and catalase/peroxidases. Alcohol Clin Exp Res 24:1433–1442.
   PubMedGoogle Scholar
• Roman RJ. (2002). P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131–185.
   PubMed Web of Science ®Google Scholar
• Stohs SJ. (1995). The role of free radicals in toxicity and disease. J Basic Clin Physiol Pharmacol 6:205–228.
   PubMedGoogle Scholar
• Stroes ES, Lüscher TF, de Groot FG, Koomans HA, Rabelink TJ. (1997). Cyclosporin A increases nitric oxide activity in vivo. Hypertension 29:570–575.
   PubMedGoogle Scholar
• Trevisan R, Dodesini AR, Lepore G. (2006). Lipids and renal disease. J Am Soc Nephrol 17:S145–S147.
   PubMed Web of Science ®Google Scholar
• Wang C, Salahudeen AK. (1995). Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int 47:927–934.
   PubMed Web of Science ®Google Scholar
• Wu D, Cederbaum A. (2004). Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-kappaB DNA binding activity. Mol Pharmacol 66:749–760.
   PubMed Web of Science ®Google Scholar
• Wu D, Cederbaum A. (2008a). Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice. Hepatology 47:1005–1017.
   PubMed Web of Science ®Google Scholar
• Wu D, Cederbaum AI. (2008b). Development and properties of HepG2 cells that constitutively express CYP2E1. Methods Mol Biol 447:137–150.
   PubMedGoogle Scholar
• Yang DW, Jia RH, Yang DP, Ding GH, Huang CX. (2004). Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J 117:542–546.
   PubMed Web of Science ®Google Scholar
• Zaher H, Buters JT, Ward JM, Bruno MK, Lucas AM, Stern ST, Cohen SD, Gonzalez FJ. (1998). Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol 152:193–199.
   PubMed Web of Science ®Google Scholar
• Zhao X, Imig JD. (2003). Kidney CYP450 enzymes: biological actions beyond drug metabolism. Curr Drug Metab 4:73–84.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Arteel GE, Connor HD, Yin M, Frankenberg MV, Stachlewitz RF, Raleigh JA, Mason RP, Thurman RG. (1998). Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 275(Pt 2):F595–F604.
   Google Scholar